NDAQ:LUNG - Post Discussion
Pulmonx Corp
> PULMONX: BREATH OF FRESH AIR FOR LUNG DISEASE PATIENTS
Post by
AviseAnalytics on Jun 27, 2023 9:03am
PULMONX: BREATH OF FRESH AIR FOR LUNG DISEASE PATIENTS
Excited to share an article about Pulmonx Corp (NASDAQ: LUNG), a global leader in minimally invasive treatments for lung disease. The Company has created a highly effective solution for patients with severe emphysema.
Pulmonx operates in an industry where the target market has highly unmet medical needs - thus, by providing a valuable and well-received solution, it may succeed in scaling new heights.
Read on to know more https://www.aviseanalytics.com/pulmonx-breath-of-fresh-air-for-lung-disease-patients/
Be the first to comment on this post